Cargando…
Application of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination
INTRODUCTION: Identification of adverse events and determination of their seriousness ensures timely detection of potential patient safety concerns. Adverse event seriousness is a key factor in defining reporting timelines and is often performed manually by pharmacovigilance experts. The dramatic in...
Autores principales: | Routray, Ramani, Tetarenko, Niki, Abu-Assal, Claire, Mockute, Ruta, Assuncao, Bruno, Chen, Hanqing, Bao, Shenghua, Danysz, Karolina, Desai, Sameen, Cicirello, Salvatore, Willis, Van, Alford, Sharon Hensley, Krishnamurthy, Vivek, Mingle, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965337/ https://www.ncbi.nlm.nih.gov/pubmed/31605285 http://dx.doi.org/10.1007/s40264-019-00869-4 |
Ejemplares similares
-
Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing
por: Abatemarco, Danielle, et al.
Publicado: (2018) -
Artificial Intelligence and the Future of the Drug Safety Professional
por: Danysz, Karolina, et al.
Publicado: (2018) -
Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020) -
A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication
por: Choi, Yeo Jin, et al.
Publicado: (2023) -
Pleasures and pains of running a pharmacovigilance center
por: Dikshit, R.K., et al.
Publicado: (2008)